Effect of treatment with pegvisomant on meningioma growth in vivo.
Drake
W M
WM
Grossman
A B
AB
Hutson
R K
RK
D000172:Acromegaly / Q000150:complications / Q000188:drug therapy*; D000368:Aged; D005260:Female; D019382:Human Growth Hormone / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008579:Meningioma / Q000150:complications / Q000188:drug therapy*; D015282:Octreotide / Q000627:therapeutic use; D010911:Pituitary Neoplasms / Q000150:complications / Q000188:drug therapy*; D011986:Receptors, Somatotropin / Q000037:antagonists & inhibitors
D011986:Receptors, Somatotropin; D019382:Human Growth Hormone; C406545:pegvisomant; D015282:Octreotide